A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowyc (Q44305365)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowyc |
scientific article |
Statements
1 reference
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowyc (English)
1 reference
Ranju Singh
1 reference
Yamini Menon
1 reference
Raquel Cuchacovich
1 reference
Luis R Espinoza
1 reference
1 February 2003
1 reference
1 reference
48
1 reference
2
1 reference
583-4; author reply 584
1 reference
Identifiers
1 reference
1 reference